Head-to-head
Oak Longevity vs NovoCare Pharmacy (Wegovy)
Compared on semaglutide across the eight dimensions this database records. They differ on 6 of those eight. Oak Longevity is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Oak Longevity is $133 a month all-in for semaglutide; NovoCare Pharmacy (Wegovy) is $349. Over twelve months that is $1,596 against $4,188. Value Scores are 95.6 and 45.9 out of 100.
Semaglutide
Plan pages: Oak Longevity plans · NovoCare Pharmacy (Wegovy) plans
At 2.4 mg/week, Oak Longevity is $133 a month all-in and NovoCare Pharmacy (Wegovy) is $349 — $216 apart, or $2,592 across a year. Over twelve months the totals are $1,596 (billed monthly) and $4,188 (billed monthly).
Oak Longevity charges a flat $133 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
NovoCare Pharmacy (Wegovy) charges a flat $349 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | Oak Longevity | Rank | NovoCare Pharmacy (Wegovy) | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $133 | 4/32 | $349 | 31/32 | Oak Longevity by $216 |
| 0.5 mg | $133 | 3/21 | $349 | 21/21 | Oak Longevity by $216 |
| 1 mg | $133 | 3/21 | $349 | 21/21 | Oak Longevity by $216 |
| 1.7 mg | $133 | 3/21 | $349 | 21/21 | Oak Longevity by $216 |
| 2.4 mg | $133 | 3/29 | $349 | 27/29 | Oak Longevity by $216 |
Oak Longevity is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, Oak Longevity sits 2 of 29 on all-in monthly cost and NovoCare Pharmacy (Wegovy) sits 26. There are 23 other programs priced between them. The field median is $249 and the floor is $129, so Oak Longevity is below the median and the other is above it. Oak Longevity is $4 above the cheapest semaglutide program on record. NovoCare Pharmacy (Wegovy) is $220 above the cheapest semaglutide program on record.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — Oak Longevity undercuts it by $216, NovoCare Pharmacy (Wegovy) by $0. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Oak Longevity | NovoCare Pharmacy (Wegovy) | Cheaper |
|---|---|---|---|
| Month to month | $133 | $349 | Oak Longevity by $216 |
| Settled dose | Oak Longevity | NovoCare Pharmacy (Wegovy) | Difference |
|---|---|---|---|
| 0.25 mg | $1,596 | $4,188 | $2,592 apart |
| 0.5 mg | $1,596 | $4,188 | $2,592 apart |
| 1 mg | $1,596 | $4,188 | $2,592 apart |
| 1.7 mg | $1,596 | $4,188 | $2,592 apart |
| 2.4 mg | $1,596 | $4,188 | $2,592 apart |
Oak Longevity publishes no rate for 3-month term, 6-month term, 12-month term; NovoCare Pharmacy (Wegovy) publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $1,596 on Oak Longevity and $4,188 on NovoCare Pharmacy (Wegovy). The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
Value Scores are 95.6 for Oak Longevity and 45.9 for NovoCare Pharmacy (Wegovy), against a semaglutide category floor of $129. Oak Longevity leads by 49.7 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Oak Longevity | 67.9 | 12.8 | 10 | 5 | 95.6 |
| NovoCare Pharmacy (Wegovy) | 25.9 | 15.0 | 0 | 5 | 45.9 |
Where the two programs differ
All-in monthly
Oak Longevity is cheaper month to month — $133 against $349, a gap of $216 every month, or $2,592 across a year if both rates hold.
Cancellation terms
Cancellation differs: Oak Longevity states Cancel before renewal, while NovoCare Pharmacy (Wegovy) states No subscription lock. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Oak Longevity asks for Month-to-month; NovoCare Pharmacy (Wegovy) asks for None. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
Oak Longevity charges one price at every dose; NovoCare Pharmacy (Wegovy) prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. Oak Longevity's figure is provider-stated and NovoCare Pharmacy (Wegovy)'s is verified. NovoCare Pharmacy (Wegovy) rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $1,596 for Oak Longevity and $4,188 for NovoCare Pharmacy (Wegovy). Oak Longevity is lower by $2,592 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Oak Longevity Official site
A small cash-pay telehealth program whose $133/month flat semaglutide price is currently the lowest month-to-month figure in our semaglutide index.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly itemized), so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Availability confirmed at intake.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — First-party pricing page capture 2026-08-08
Watch: Small operator; pharmacy partner not publicly itemized. Price captured from the provider's published pages; checkout capture pending.
NovoCare Pharmacy (Wegovy) Official site
Novo Nordisk's direct cash pharmacy sells FDA-approved Wegovy pens at $349/month across standard doses ($399 for the 7.2 mg HD pen), with a $199 introductory price on the first two starter-dose fills and oral Wegovy tablets from $149/month. It is the FDA-approved semaglutide price floor and the benchmark for every compounded semaglutide quote.
It names its compounding pharmacy — CoAssist Pharmacy d/b/a NovoCare Pharmacy, recorded as Manufacturer direct — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None; cancellation is No subscription lock; availability is stated as 50 states.
Evidence: verified — captured at checkout by our desk on the stated date, captured . Source — novocare.com price guide and savings-offer pages, retrieved 2026-08-11
Watch: The $199 intro and the $149 oral tier both carry published expiration dates; the durable numbers are $349 pen / $399 HD.
Which molecules each one carries
Oak Longevity carries semaglutide at $133 a month; does not offer tirzepatide.
NovoCare Pharmacy (Wegovy) carries semaglutide at $349 a month; does not offer tirzepatide.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Oak Longevity does not publish
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Availability confirmed at intake
NovoCare Pharmacy (Wegovy) does not publish
- no published twelve-month semaglutide rate
Ask Oak Longevity and NovoCare Pharmacy (Wegovy) for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Neither program publishes a promotional rate with an end date, a prepaid term, or a price we have flagged for re-verification, so the comparison above is as stable as this dataset gets.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, Oak Longevity Official site wins this matchup. If you expect to titrate to the top of the ladder, oak longevity's flat pricing is worth more than the headline gap suggests; and if you would rather trust a better-evidenced number, novocare pharmacy (wegovy)'s price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Oak Longevity's semaglutide price is provider-stated as of 2026-08-08; NovoCare Pharmacy (Wegovy)'s is verified as of 2026-08-11.
Questions
Is Oak Longevity or NovoCare Pharmacy (Wegovy) cheaper for semaglutide?
Oak Longevity is cheaper on all-in monthly cost at 2.4 mg/week: $133 against $349, a difference of $216 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Oak Longevity versus NovoCare Pharmacy (Wegovy)?
Oak Longevity works out to $1,596 across twelve months and NovoCare Pharmacy (Wegovy) to $4,188, on the plan terms each publishes.
Does Oak Longevity or NovoCare Pharmacy (Wegovy) raise the price as the dose goes up?
Oak Longevity: no, it charges one flat rate at every dose. NovoCare Pharmacy (Wegovy): yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Oak Longevity and NovoCare Pharmacy (Wegovy) differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Oak Longevity and NovoCare Pharmacy (Wegovy) names its pharmacy?
NovoCare Pharmacy (Wegovy) does — CoAssist Pharmacy d/b/a NovoCare Pharmacy. Oak Longevity does not, recording only Partner 503A pharmacy (not publicly itemized), so who makes its medication cannot be independently verified.
How well evidenced are the Oak Longevity and NovoCare Pharmacy (Wegovy) prices?
Oak Longevity's semaglutide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-08. NovoCare Pharmacy (Wegovy)'s is verified, captured 2026-08-11. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Oak Longevity official site · NovoCare Pharmacy (Wegovy) official site. Compounded tirzepatide and semaglutide are not FDA-approved products.